Indaptus Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +27.5% | -6.0% | +18.3% | +3.6% | -0.6% | -99.9% | +64.7% | +26.9% | -27.9% | -42.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.0% | +146.5% | +141.2% | +45.7% | -24.7% | -90.0% | -5.0% | +150.7% | +20.5% | -4.9% | +28.8% | |
| – | – | – | – | – | – | +74.0% | +451.3% | +64.9% | +2.0% | -7.3% | +29.3% | |
| – | -1.8% | +91.8% | +117.6% | +48.4% | -19.7% | -89.4% | +114.7% | +92.9% | +9.8% | -6.2% | +29.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +6.3% | +35.3% | -34.8% | +0.8% | +17.3% | +3,218.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +255.2% | +519.4% | -102.4% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.